Text Registration
Copyright Title
Soriatane (acitretin) therapy for the management of severe psoriasis
Status
Published
on 15 Jun 2007
Year of Creation
2005
Copyright Claimant
Connectics Corporation
Registration Number
TX0006152811
on 15 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0006152811) dated 15 Jun 2007, pertains to an electronic file (eService) titled "Soriatane (acitretin) therapy for the management of severe psoriasis" created in 2005. The copyright holder is Connectics Corporation, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Connectics Corporation.
Application Details
Registration Number
TX0006152811
Registration Date
6/15/2007
Year of Creation
2005
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
SynerMed Communications
Series Statement
Medical affairs slide kit
Notes
Bibliographic Note: Cataloged from appl. only
Material Matter Claimed Note: New Matter: text
Previous Registration Note: Preexisting material: tables & figures used with permission
Statements
Author Statement: text: SynerMed Communications, employer for hire
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.